Kymera Therapeutics, Inc.
Public
KYMR
SectorHealthcare
CountryUnited States
Market cap7.07B
A clinical-stage biopharmaceutical company pioneering targeted protein degradation to discover medicines for immune-inflammatory diseases and oncology.
